Summary
0.7755 0.0000(0.0000%)08/27/2024
Helix Biopharma Corp. (HBPCF)
Helix Biopharma Corp. (HBPCF)
Key Facts
1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
0.0000 | 2.7397 | 240.9091 | 150.0000 | 87.5000 | -29.2453 | -51.2987 | 0.0000 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
Trading Data | ||
Close | 0.7755 | |
Open | 0.1378 | |
High | 0.7755 | |
Low | 0.1377 | |
Volume | 287 | |
Change | 0.0000 | |
Change % | 0.0000 | |
Avg Volume (20 Days) | ||
Volume/Avg Volume (20 Days) Ratio | inf | |
52 Week Range | 0.22 - 1.15 | |
Price vs 52 Week High | -32.57% | |
Price vs 52 Week Low | 252.50% | |
Range | 0.0000 | |
Gap Up/Down | 0.0000 |
Fundamentals | ||
Market Capitalization (Mln) | 41 | |
EBIDTA | 0 | |
PE Ratio | 0.0000 | |
PEG Ratio | 0.0000 | |
WallStreet Target Price | 0.0000 | |
Book Value | 0.0000 | |
Earnings Per Share | 0.0000 | |
EPS Estimate Current Quarter | 0.0000 | |
EPS Estimate Next Quarter | 0.0000 | |
EPS Estimate Current Year | 0.0000 | |
EPS Estimate Next Year | 0.0000 | |
Diluted EPS (TTM) | 0.0000 | |
Revenues | ||
Profit Marging | 0.0000 | |
Operating Marging (TTM) | 0.0000 | |
Return on asset (TTM) | -1.6008 | |
Return on equity (TTM) | -5.4684 | |
Revenue TTM | 0 | |
Revenue per share TTM | 0.0000 | |
Quarterly Revenue Growth (YOY) | 0.0000 | |
Quarterly Earnings Growth (YOY) | 0.0000 | |
Gross Profit (TTM) | 0 |
Dividends | ||
Dividend Share | 0.0000 | |
Dividend Yield | ||
Valuations | ||
Trailing PE | 0.0000 | |
Forward PE | 0.0000 | |
Price Sales (TTM) | 0.0000 | |
Price Book (MRQ) | 0.0000 | |
Revenue Enterprise Value | 0.0000 | |
EBITDA Enterprise Value | 0.0000 | |
Shares | ||
Shares Outstanding | 102,810,000 | |
Shares Float | 114,717,121 | |
Shares Short | 0 | |
Shares Short (Prior Month) | 0 | |
Shares Ratio | 0.00 | |
Short Outstanding (%) | 0.00 | |
Short Float (%) | 0.00 | |
Insider (%) | 16.04 | |
Institutions (%) | 19.83 |